Antonin Kröhn is an author at Roche (United Kingdom) specializing in medicinal chemistry, drug discovery, and natural sciences.
Top concepts
MedicineDrug DiscoveryNatural SciencesMedicinal ChemistryBiochemistryPharmacologyChemical BiologyDrug DevelopmentHivPharmacotherapy
Publications per year
1977–1991
7
7
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Noel A. Roberts, Joseph A. Martin, Derek Kinchington et al. · Science · 1990 · 922 citations
Antonin Kröhn, Sally Redshaw, Jenny C. Ritchie et al. · Journal of Medicinal Chemistry · 1991 · 232 citations · Full text
Potent Hiv-proteinase Inhibitors, Altmetric Attention Score, Pharmacotherapy +21
Michael R. Attwood, Cedric H. Hassall, Antonin Kröhn et al. · Journal of the Chemical Society Perkin Transactions 1 · 1986 · 100 citations
Combinatorial Chemistry, Pharmacotherapy, Chemical Biology +16
New potent inhibitors of angiotensin converting enzyme
Michael R. Attwood, RJ Francis, Cedric H. Hassall et al. · FEBS Letters · 1984 · 53 citations
Cedric H. Hassall, Antonin Kröhn, Christopher J. Moody et al. · Journal of the Chemical Society Perkin Transactions 1 · 1984 · 49 citations
Combinatorial Chemistry, Bioorganic Chemistry, Heterocycle Chemistry +17
Rows per page
1–5 of 7